Innate Pharma
IPHA
#8501
Rank
โ‚น11.13 B
Marketcap
โ‚น137.50
Share price
3.82%
Change (1 day)
-31.80%
Change (1 year)

Innate Pharma (IPHA) - Cash on Hand

Cash on Hand as of December 2023 : โ‚น8.62 Billion

According to Innate Pharma 's latest financial reports the company has โ‚น8.62 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Innate Pharma - Cash on Hand chart (from 2009 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น9.00 B-10.82%
2021-12-31โ‚น10.10 B-25.94%
2020-12-31โ‚น13.64 B-21.98%
2019-12-31โ‚น17.48 B30.47%
2018-12-31โ‚น13.40 B50.65%
2017-12-31โ‚น8.89 B-37.05%
2016-12-31โ‚น14.13 B-17.57%
2015-12-31โ‚น17.14 B221.19%
2014-12-31โ‚น5.33 B51.28%
2013-12-31โ‚น3.52 B49.34%
2012-12-31โ‚น2.36 B-26.22%
2011-12-31โ‚น3.20 B55.34%
2010-12-31โ‚น2.06 B-36.97%
2009-12-31โ‚น3.27 B43.85%
2008-12-31โ‚น2.27 B-21.88%
2007-12-31โ‚น2.90 B-16.77%
2006-12-31โ‚น3.49 B257.56%
2005-12-31โ‚น0.97 B